T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination
在接受抗CD20治疗的多发性硬化症患者接种SARS-CoV-2 mRNA疫苗后,T细胞活化标志物CD38和HLA-DR未发生血清转化。
期刊:Journal of Neurology Neurosurgery and Psychiatry
影响因子:7.5
doi:10.1136/jnnp-2023-332224
Verstegen, Niels J M; Hagen, Ruth R; Kreher, Christine; Kuijper, Lisan H; Dijssel, Jet van den; Ashhurst, Thomas; Kummer, Laura Y L; Palomares Cabeza, Virginia; Steenhuis, Maurice; Duurland, Mariël C; Jongh, Rivka de; Schoot, C Ellen van der; Konijn, Veronique A L; Mul, Erik; Kedzierska, Katherine; van Dam, Koos P J; Stalman, Eileen W; Boekel, Laura; Wolbink, Gertjan; Tas, Sander W; Killestein, Joep; Rispens, Theo; Wieske, Luuk; Kuijpers, Taco W; Eftimov, Filip; van Kempen, Zoé L E; van Ham, S Marieke; Ten Brinke, Anja; van de Sandt, Carolien E
SARS-CoV-2
T细胞
神经科学
多发性硬化症
CD3
CD20
T细胞
CD38
细胞生物学
CD2
免疫/内分泌